Retrograde delivery of photosensitizer (TPPp-O-β-GluOH)3 selectively potentiates its photodynamic activity

Bioconjugate Chemistry

Volumn 19, Issue 2, 2008, Pages 532-538

  Amessou, Mohamed ^a   Carrez, Danièle ^b,c   Patin, Delphine ^a   Sarr, Marianne ^a   Grierson, David S ^b,d,e   Croisy, Alain ^b,c   Tedesco, Antonio C ^f   Maillard, Philippe ^b,d   Johannes, Ludger ^a  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

^c Centre Universitaire   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; PHOTODYNAMIC THERAPY; TARGETED DRUG DELIVERY; TUMORS;

BINDING AFFINITIES; CANCEROUS TISSUES; CHEMICAL COUPLING; GLYCOSPHINGOLIPIDS; PHOTODYNAMIC ACTIVITIES; PHOTOSENSITISER; SHIGA TOXIN; SULFHYDRYL; TUMOUR CELLS; VISIBLE LIGHT;

PHOTOSENSITIZERS;

5,10,15 TRIS[4 (2',3',4',6' TERTACETYL O BETA DEXTRO GLUCOSYLOXYPHENYL)] 20 (4 BROMOMETHYLPHENYL)PORPHYRIN; GLYCOSPHINGOLIPID; OXYGEN; PHOTOSENSITIZING AGENT; PORPHYRIN DERIVATIVE; PROTEIN SUBUNIT; SHIGA TOXIN; UNCLASSIFIED DRUG; VEROTOXIN 1;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATALYSIS; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTESTINE CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; PHOTODYNAMICS;

EID: 39749174945     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc7003999     Document Type: Article

References (38)

1. Dubowchik, G. M., and Walker, M. A. (1999) Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs. Pharmacol. Ther. 83, 67-123.
2. Dyba, M., Tarasova, N. I., and Michejda, C. J. (2004) Small molecule toxins targeting tumor receptors. Curr. Pharm. Des. 10, 2311-2334.
3. Mangeney, M., Richard, Y., Coulaud, D., Tursz, T., and Wiels, J. (1991) CD77: An antigen of germinal center B cells entering apoptosis. Eur. J. Immunol. 21, 1131-1140.
4. LaCasse, E. C., Bray, M. R., Patterson, B., Lim, W. M., Perampalam, S., Radvanyi, L. G., Keating, A., Stewart, A. K., Buckstein, R., Sandhu, J. S., Miller, N., Banerjee, D., Singh, D., Belch, A. R., Pilarski, L. M., and Gariepy, J. (1999) Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: Implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94, 2901-2910.
5. Arab, S., Rutka, J., and Lingwood, C. (1999) Verotoxin induces apoptosis and the complete, rapid, long-term elimination of human astrocytoma xenografts in nude mice. Oncol. Res. 11, 33-39.
6. Arab, S., Russel, E., Chapman, W. B., Rosen, B., and Lingwood, C. A. (1997) Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias. Oncol. Res. 9, 553-563.
7. Kovbasnjuk, O., Mourtazina, R., Baibakov, B., Wang, T., Elowsky, C., Choti, M. A., Kane, A., and Donowitz, M. (2006) The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. U.S.A. 102, 19087-19092.
8. Ohyama, C., Fukushi, Y., Satoh, M., Saitoh, S., Orikasa, S., Nudelman, E., Straud, M., and Hakomori, S. (1990) Changes in glycolipid expression in human testicular tumor. Int. J. Cancer 45, 1040-1044.
9. O'Brien, A. D., Tesh, V. L., Donohue-Rolfe, A., Jackson, M. P., Olsnes, S., Sandvig, K., Lindberg, A. A., and Keusch, G. T. (1992) Shiga toxin: Biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180, 65-94.
10. Johannes, L., and Decaudin, D. (2005) Protein toxins: Intracellular trafficking for targeted therapy. Gene Ther. 16, 1360-1368.
11. Sandvig, K., and van Deurs, B. (2005) Delivery into cells: Lessons learned from plant and bacterial toxins. Gene Ther. 12, 865-872.
12. Janssen, K.-P., Vignjevic, D., Boisgard, R., Falguières, T., Bousquet, G., Decaudin, D., Dollé, F., Louvard, D., Tavitian, B., Robine, S., and Johannes, L. (2006) In vivo tumor targeting using a novel intestinal pathogen-based delivery approach. Cancer Res. 66, 7230-7236.
13. Ishitoya, S., Kurazono, H., Nishiyama, H., Nakamura, E., Kamoto, T., Habuchi, T., Terai, A., Ogawa, O., and Yamamoto, S. (2004) Verotoxin induces rapid elimination of human renal tumor xenografts in SCID mice. J. Urol. 171, 1309-1313.
14. Heath-Engel, H. M., and Lingwood, C. A. (2003) Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker. Angiogenesis 6, 129-141.
15. Salhia, B., Rutka, J. T., Lingwood, C., Nutikka, A., and Van Furth, W. R. (2002) The treatment of malignant meningioma with verotoxin. Neoplasia 4, 304-311.
16. LaCasse, E. C., Saleh, M. T., Patterson, B., Minden, M. D., and Gariepy, J. (1996) Shiga-like toxin purges human lymphoma from bone manow of severe combined immunodeficient mice. Blood 88, 1561-1567.
17. El Alaoui, A., Schmidt, F., Amessou, M., Florent, J. C., and Johannes, L. (2007) Shiga toxin-mediated retrograde delivery of a topoisomerase I inhibitor prodrug. Angew. Chem., Int. Ed. 46, 6469-6472.
18. Tanago-Trani, M. T., Jiang, S., Harich, K. C., and Storrie, B. (2006) Shiga-like toxin subunit B (SLTB)-enhanced delivery of chlorin e6 (Ce6) improves cell killing. Photochem. Photobiol. 82, 527-537.
19. MacDonald, I. J., and Dougherty, T. J. (2001) Basic principles of photodynamic therapy. J. Porphyrins Phthalocyanines 5, 105-129.
20. Wojtyk, J. T., Goyan, R., Gudgin-Dickson, E., and Pottier, R. (2006) Exploiting tumour biology to develop novel drug delivery strategies for PDT. Med. Laser Appl. 21, 225-238.
21. Sharman, W. M., van Lier, J. E., and Allen, C. M. (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Delivery Rev. 56, 53-76.
22. Halazy, S., Berges, V., Ehrhard, A., and Danzin, C. (1990) Ortho- and para-(difluoromethyl)aryl-β-image-glucosides: A new class of enzyme-activated ineversible inhibitors of β-glucosidases. Bioorg. Chem. 18, 330-344.
23. Wen, L., Li, M., and Schlenoff, J. B. (1997) Polyporphyrin thin films from interfacial polymerization of mercaptoporphyrins. J. Am. Chem. Soc. 119, 7726-7733.
24. Lindsey, J. S., Schreiman, I. C., Hsu, H. C., Kearney, P. C., and Marguerettaz, A. M. (1987) Rothemund and Adler-Longo reactions revisited: Synthesis of tetraphenylporphyrins under equilibrium conditions. J. Org. Chem. 52, 827-836.
25. Zemplén, G. (1927) Abbau der reduzierenden biosen. Ber. Dtsch. Chem. Ges. 1555-1564.
26. Oulmi, D., Maillard, P., Guerquin-Kern, J.-L., Huel, C., and Momenteau, M. (1995) Glyconjugated porphyrins. 3 Synthesis of flat amphiphilic meso-(glycosylated-aryl)-aryl porphyrins and mixed meso-(glycosylated-aryl)- alkyl porphyrins bearing some mono and disaccharide groups. J. Org. Chem. 60, 1554-1564.
27. Haicheur, N., Benchetrit, F., Amessou, M., Leclerc, C., Falguières, T., Fayolle, C., Bismuth, E., Fridman, W. H., Johannes, L., and Tartour, E. (2003) The B-subunit of Shiga toxin coupled to full-size protein elicits humoral and cellular immune responses associated with a TH1 dominant polarization. Int. Immunol. 15, 1161-1171.
28. Johannes, L., Tenza, D., Antony, C., and Goud, B. (1997) Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 272, 19554-19561.
29. Abe, A., Inokuchi, J., Jimbo, M., Shimeno, H., Nagamatsu, A., Shayman, J. A., Shukla, G. S., and Radin, N. S. (1992) Improved inhibitors of glucosylceramide synthase. J. Biochem. 111, 191-196.
30. Mallard, F., Tenza, D., Antony, C., Salamero, J., Goud, B., and Johannes, L. (1998) Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of Shiga toxin B-fragment transport. J. Cell Biol. 143, 973-990.
31. Sharkey, R. M., and Goldenberg, D. M. (2006) Targeted therapy of cancer: New prospects for antibodies and immunoconjugates. CA Cancer J. Clin. 56, 226-243.
32. Mellor, H. (2004) Cell motility: Golgi signalling shapes up to ship out. Curr. Biol. 14, R434-R435.
33. Mor, A., and Philips, M. R. (2006) Compartmentalized Ras/MAPK signaling. Annu. Rev. Immunol. 24, 771-800.
34. Boelens, J., Lust, S., Offner, F., Bracke, M. E., and Vanhoecke, B. W. (2007) Review. The endoplasmic reticulum: A target for new anticancer drugs. In Vivo 21, 215-226.
35. Pina, D. G., Gomez, J., Villar, E., Johannes, L., and Shnyrov, V. L. (2003) Thermodynamic analysis of the structural stability of Shiga toxin B-subunit. Biochemistry 42, 9498-9506.
36. Mallard, F., and Johannes, L. (2003) Shiga toxin B-subunit as a tool to study retrograde transport. In Methods in Molecular Medicine: Shiga Toxin Methods and Protocols (Philpott, D., and Ebel, F., Eds.), Vol. 73, Chapter 17, pp 209-220.
37. Bautista-Sanches, A., Kasselouri, T., Desroches, M. C., Blais, J., Maillard, P., de Oliveira, D. M., Tedesco, A. C., Prognon, P., and Delaire, J. (2005) Photophysical properties of glucoconjugated chlorins and porphyrins and their associations with cyclodextrins. J. Photochem. Photobiol., B 81, 154-162.
38. Spiller, W., Kliesch, H., Wohrie, D., Hackbarth, S., Roder, B., and Schnurpfeil, G. (1998) Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions. J. Porphyrins Phthalocyanines 2, 145-158.